Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Depreciation & Amortization
Dexcom Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Depreciation & Amortization
$196.9m
|
CAGR 3-Years
38%
|
CAGR 5-Years
43%
|
CAGR 10-Years
39%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Depreciation & Amortization
$2.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
$1.2B
|
CAGR 3-Years
66%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
$1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
$3.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
$472.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
21%
|
See Also
What is Dexcom Inc's Depreciation & Amortization?
Depreciation & Amortization
196.9m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Depreciation & Amortization amounts to 196.9m USD.
What is Dexcom Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
39%
Over the last year, the Depreciation & Amortization growth was 23%. The average annual Depreciation & Amortization growth rates for Dexcom Inc have been 38% over the past three years , 43% over the past five years , and 39% over the past ten years .